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TO THE EDITOR
We read with interest the article entitled
‘‘IGF-1 signalling controls the hair
growth cycle and the differentiation of
hair shafts’’ (Weger and Schlake, 2005).
Recently, we have reported docu-
mentation of the role of primary IGF-1
deficiency on hair structure in human
beings (Lurie et al., 2004). Laron
syndrome is a recessively inherited
disease of primary IGF-1 deficiency
owing to primary growth hormone
insensitivity. Affected children have
sparse hair growth and frontal reces-
sions. The hair is thin and easy to pluck,
and young adults have various degrees
of alopecia. Despite signs of early
aging, graying of the hair is delayed
and reduced (Laron, 2004). The syn-
drome is caused by deletions or muta-
tions in the growth hormone receptor or
postreceptor pathways, which lead to
an inability to generate IGF-1 (Laron,
2002, 2004). We investigated the effect
of primary IGF-1 deficiency on hair
structure by sampling the hair of 11
patients with Laron syndrome. The most
significant structured defect, pili torti et
canaliculi, was found in two young,
untreated patients. Grooving, tapered
hair, and trichorrhexis nodosa were
found in the remainder. IGF-1-treated
patients had either none or significantly
fewer pathological changes compared
to the untreated patients.
We believe our report (Lurie et al.,
2004) supplements that of Weger and
Schlake (2005) in demonstrating the
regulatory function of IGF-1 on hair
growth in man from a different direction.
D. Ben Amitai1, R. Lurie1 and Z. Laron2,3
1Units of Pediatric Dermatology, Schneider
Children’s Medical Center of Israel, Petah
Tiqva, Israel; 2Units of Endocrinology and
Diabetes Research, Schneider Children’s
Medical Center of Israel, Petach Tiqva,
Israel and 3Units of Endocrinology and
Diabetes Research, Sackler Faculty of
Medicine, Tel Aviv University, Tel Aviv,
Israel. E-mail: danb@clalit.org.il
REFERENCES
Laron Z (2002) Growth hormone insensitivity
(Laron syndrome). Rev Endocr Metab Disord
3:347–55
Laron Z (2004) Laron syndrome (primary growth
hormone resistance or insensitivity): the
personal experience 1958–2003. J Clin Endo-
crinol Metab 89:1031–44
Lurie R, Ben-Amitai D, Laron Z (2004) Laron
syndrome (primary growth hormone insen-
sitivity): a unique model to explore the
effect of insulin-like growth factor 1 defi-
ciency on human hair. Dermatology 208:
314–8
Weger N, Schlake T (2005) Igf-I signalling controls
the hair growth cycle and the differen-
tiation of hair shafts. J Invest Dermatol 125:
873–82
Response to Ben Amitai et al.
Journal of Investigative Dermatology (2006) 126, 2135–2136. doi:10.1038/sj.jid.5700437; published online 15 June 2006
Whereas IGF-I has been initially de-
scribed as a potent mitogen supporting
cell growth and survival (Stewart and
Rotwein, 1996), there is accumulating
evidence for its participation in diverse
differentiation processes (Musaro and
Rosenthal, 1999; Hsieh et al., 2004).
Our recent work on IGF-I confirmed
this dual role for the murine hair follicle
(Weger and Schlake, 2005a, b). In man,
an IGF-I deficiency is associated with
Laron syndrome (Laron, 2002). Interest-
ingly, patients show impaired hair
production and structural abnormalities
of hair shafts (Lurie et al., 2004). On the
molecular level, people with Laron
syndrome are similar to Ivl::Igfbp3 mice
that are supposed to have reduced
levels of freely available IGF-I. The
suppression of endogenous signalling
in these mice causes a remarkable
thinning of hair shafts that has been
also described for Laron syndrome
(Lurie et al., 2004; Weger and Schlake,
2005b); by contrast, overexpression of
Igf-I appeared to increase murine hair
thickness (Weger and Schlake, 2005a).
However, other structural defects of
hair shafts were only observed in
Ivl::Igf-I mice (Weger and Schlake,
2005a); Ivl::Igfbp3 hair shafts looked
fairly normal as opposed to hair from
Laron syndrome patients (Lurie et al.,
2004; Weger and Schlake, 2005b). This
discrepancy between man and mouse
might be owing to several reasons:
firstly, it may point to a fundamental
difference between these species.
Actually, there is already precedence
for structural diversity; whereas the
murine hair shaft medulla forms easily
visible air spaces during differentia-
tion, they are lacking in human hair.
Secondly, it is possible that the
obtained suppression of IGF-I signalling
in Ivl::Igfbp3 mice is lower than in
people suffering from Laron syndrome.
However, data on mouse lines with
significantly different expression levels
of Igfbp3 suggest that effects are re-
stricted to quantitative alterations of
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